(502 products available)
Tirzepatide 10mg peptide is a novel medication that combines three different GLP-1 receptor agonist actions into one peptide. The diversity in its mechanisms allows it to tackle multiple aspects of type 2 diabetes and obesity, such as increasing insulin secretion, decreasing glucagon, and slowing gastric emptying.
It is marketed in two forms for subcutaneous injection, with variations primarily in the dosing schedules.
Once-weekly formulation
This formulation provides sustained release and prolongs its biological activity. The extended action promotes insulin secretion in response to blood glucose levels while reducing glucagon secretion.
Twice-weekly formulation
The formulation allows for a more frequent dosing schedule. It may be beneficial for patients who prefer or tolerate more frequent injections. This formulation tends to be more effective in some patients due to its more frequent action. It effectively slows gastric emptying compared to the once-weekly version, leading to reduced appetite and increased satiety.
The composition of tirzepatide may differ based on the manufacturer, however, they will include the following ingredients:
L- amino acids
These are the basic building blocks of the tirzepatide molecule. Each amino acid in the sequence plays a crucial role in determining the peptide's biological activity, stability, and interaction with GLP-1 receptors. Commonly used L-amino acids in peptides include L-alanine, L-lysine, and L-glutamic acid.
Sodium phosphate
It is commonly used in pharmaceutical formulations to help maintain the stability of the peptide. It is also used to help maintain the proper pH level of the solution to ensure the drug remains effective and safe for use.
Water for injection
This is the primary solvent used in the preparation of tirzepatide. It ensures the peptide is delivered in a form that is safe for the body to absorb. Pure, sterile water is vital for maintaining the drug's efficacy and safety, especially in injectable formulations.
Sodium chloride
This is added mainly to adjust the osmolarity of the solution, making it more compatible with body tissues. It ensures that the peptide maintains its proper conformation and biological activity once inside the body. It plays a vital role in ensuring the stability of the peptide during its shelf life.
Tirzepatide is administered as a subcutaneous injection in the abdomen, thigh, or upper arm and should be injected in different body areas each time to avoid tissue damage. Avoid injecting into areas that are red, hardened, or scarred. Store unused tirzepatide pens in the refrigerator, however, allow the pen to reach room temperature for 30 minutes before injecting. For the 10mg peptide, it should be injected once weekly or twice weekly, depending on the doctor's prescription. The dose can be increased gradually, where for diabetes management, the dosage can increase once weekly to 15mg after four to five weeks of the initial 0.5mg dose. For patients with obesity, the dosage can increase to 10mg weekly and finally to 15mg weekly after 16 weeks of administration of the initial 3mg dose.
The long-term safety profile of tirzepatide is currently being studied in several ongoing clinical trials. However, the known safety and efficacy have been established based on data from completed trials. Following are known side effects.
Thyroid C-cell Tumors
Tirzepatide may increase the risk of thyroid C-cell tumors. This is based on studies in animals where the drug caused medullary thyroid carcinoma (MTC). Because of this potential risk, users who have a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2) are generally advised against using tirzepatide.
Pancreatitis
There is a risk of developing pancreatitis, which may be severe and lead to death. Patients may experience symptoms such as persistent abdominal pain, nausea, vomiting, or diarrhea. Patients are advised to discontinue the use of tirzepatide immediately if they experience symptoms of pancreatitis.
Diabetic Retinopathy
Users should be particularly careful when considering tirzepatide if they already have diabetic retinopathy. The drug is known to potentially worsen the condition by increasing retinal capillary leakage.
Insulin and Other Antidiabetic Medications
Tirzepatide may have an additive effect with insulin and other antidiabetic drugs that increase the risk of hypoglycemia.
Oral Medications
Tirzepatide can affect the absorption of other orally administered drugs by slowing gastric emptying. This may reduce the effectiveness of oral medications that need to be rapidly absorbed.
Anticoagulants and Antiplatelet Agents
Tirzepatide may slightly increase the risk of bleeding. This happens especially if it is used with anticoagulants such as warfarin or direct-acting antiplatelet drugs.
Tirzepatide can be shipped through various methods, each offering different transit times, costs, and levels of tracking and insurance. Common shipping methods include air freight, sea freight, and courier services. Buyers also need to consider the shipping costs, which may be influenced by the chosen method, the destination, and the weight/volume of the order. In some cases, they may negotiate directly with the supplier or freight provider.
The price of tirzepatide is influenced by a multitude of factors, key among them being:
Tirzepatide's mechanism of action is unique; it mimics two incretin hormones, GIP and GLP-1. This allows it to address multiple pathways involved in glucose regulation and weight control simultaneously.
The dual action has been shown to improve glycemic control, reduce body weight, and increase satiety, making it an attractive option for patients with obesity and type 2 diabetes. This efficacy has led to a growing interest in tirzepatide as a treatment within the endocrinology community.
The FDA approval of tirzepatide for chronic weight management has greatly enhanced its market potential. It has earned a spot in the obesity treatment space and is considered a named medication for patients struggling with weight-related health issues. T irzepatide has been nicknamed the " obesity drug" due to its effectiveness in off-label use for weight loss.
Research is continuously being done on tirzepatide's potential applications beyond diabetes and obesity. For example, studies are investigating its effects on cardiovascular health, which could broaden its use and appeal as a multi-benefit medication.
Selecting a trusted supplier or manufacturer for tirzepatide requires careful consideration of several factors to ensure quality, reliability, and legality.
Reputation and Reviews
The supplier's or manufacturer's reputation in the market will indicate the quality and reliability of their products. Look for online reviews, testimonials, and industry endorsements. Consider suppliers with experience in the pharmaceutical or biotech field as they are likely to be more knowledgeable about peptide synthesis and storage.
Product Quality and Standards
Ensure that the supplier or manufacturer adheres to strict quality control standards in the production of tirzepatide. Check whether they comply with Good Manufacturing Practices (GMP) regulations, which are essential for ensuring the purity, potency, and consistency of the peptide. Requesting a Certificate of Analysis (COA) for the product is a must as it provides information on the product's quality and safety.
Regulatory Compliance
Ensure the supplier operates legally and complies with local and international regulations. This is especially important when purchasing controlled substances like tirzepatide. Verify whether they have the necessary licenses and certifications to manufacture and distribute pharmaceutical products.
Customer Support and Communication
A reliable supplier should offer excellent customer support. They should be responsive, transparent, and proactive in communications. In case of any issues with the order, product quality, or shipment delays, good customer support is key to resolving problems quickly and efficiently.
Sourcing and Storage of Ingredients
A reputable supplier should be able to tell you about how they source their raw materials and maintain proper storage conditions for tirzepatide. Verify whether they use high-quality, ethically sourced raw materials for peptide synthesis. Additionally, ask how they maintain a proper cold chain for the storage and shipment of peptides to ensure product stability and efficacy.
A1. Tirzepatide is approved by the FDA for long term use in managing type 2 diabetes and chronic obesity. GLP-1 receptor agonists like tirzepatide are intended for long-term use to regulate blood sugar and assist in weight management.However, users should have regular follow-up with their healthcare providers to monitor effectiveness and any potential side effects.
A2. Tirzepatide is mainly used to treat type 2 diabetes and reduce the risks of cardiovascular events. It is commonly used off-label for weight management in people without diabetes due to its significant effects on appetite and weight loss .
A3. There are other medications that offer similar mechanisms and benefits. These are also GLP-1 receptor agonists like semaglutide and exenatide. However, they do not combine the actions of GIP and GLP-1 as tirzepatide does. For patients seeking different treatment options, other antihyperglycemic drugs like metformin may be used, especially those who do not require injection.
A4. Users should have regular monitoring of their thyroid function tests due to the risk of thyroid tumors. Careful assessment of pancreatitis symptoms, including abdominal pain and nausea is important because the drug may worsen or induce pancreatitis. It is important to discontinue the use of tirzepatide and seek medical attention when experiencing these symptoms. Users should also be screened for diabetic retinopathy before beginning treatment and monitored regularly.